dj Orthopedics to Present at the 22nd Annual JPMorgan Healthcare Conference
SAN DIEGO, Jan 05, 2004 /PRNewswire-FirstCall via Comtex/ -- dj Orthopedics, Inc., (NYSE: DJO), a designer, manufacturer and marketer of products and services for the orthopedic sports medicine market, today announced that the Company has been invited to make a presentation to healthcare investors at the 22nd Annual JPMorgan Healthcare Conference, held at the Westin St. Francis Hotel in San Francisco, California. The Company's presentation will focus on its strategy and position within its markets. All interested investors may listen to the presentation live via webcast beginning at 3:00 PM Pacific Time, 6:00 PM Eastern Time, on Monday, January 12, 2004 by copying and pasting the URL listed below into an Internet browser, then clicking on the appropriate link to register for the webcast. The webcast also will be archived approximately three hours after the live event and will be available for three months, terminating on April 16, 2004. Webcast URL: http://equityconferences.jpmorgan.com .
About dj Orthopedics, Inc.
dj Orthopedics is a global orthopedic sports medicine company focused on the design, manufacture and marketing of products and services that regenerate and rehabilitate soft tissue and bone after trauma, help protect against injury and treat
osteoarthritis of the knee. Its broad range of over 600 rehabilitation products, many of which are based on proprietary technologies, includes rigid knee braces, soft goods, specialty and other complementary orthopedic products such as cold therapy and pain management systems. The Company's regeneration products consist of two bone growth stimulation devices,
the OL1000, approved by the FDA in 1994, which utilizes patented Combined Magnetic Field technology to deliver a highly specific, low- energy signal for the non-invasive treatment of an established nonunion fracture acquired secondary to trauma, excluding vertebrae and all flat bones, and SpinaLogic®, a state-of-the-art device used as an adjunct to primary lumbar
spinal fusion surgery for one or two levels, approved by the FDA in late 1999. The Company's products provide solutions for orthopedic professionals and their patients throughout the patient's continuum of care. For more information, visit the Company's website at www.djortho.com .
SOURCE dj Orthopedics, Inc.
http://www.prnewswire.com
Company Investor/Media Contact:
DJO Incorporated
Mark Francois
Director of Corporate Communications & Investor Relations
760-734-4766
Mark.Francois[at]djoglobal[dot]com
